Phase Forward to Participate in Six Industry Events in November
November 03 2009 - 9:00AM
Business Wire
Phase Forward (NASDAQ: PFWD), a leading provider of data
management solutions for clinical trials and drug safety, will
participate in six industry events this month including the
ChinaTrials Global Clinical Development Summit and CBI’s 5th Forum
on Patient Reported Outcomes (PRO).
At the ChinaTrials Global Clinical Development Summit, November
8-10, in Beijing, China, Phase Forward (booth # 22) Regional
Director and General Manager Jon Carrano will moderate a panel on
EDC in China. Session details are as follows:
Who: Jon Carrano, Ph.D., Regional
Director and General Manager, Phase Forward (Moderator)What:
“Electronic Data Capture and Clinical Data Management in
China”When: Tuesday, November 10, 10:10-11:10 a.m. local
time
At CBI’s 5th Forum on Patient Reported Outcomes, November 17-18,
in Philadelphia, Pa., Phase Forward will exhibit its late phase
solutions and Vice President and Conference Chair Scott Dixon will
participate in the following session:
Who: Scott Dixon, Vice President,
Outcome Logix Group, Phase Forward (Moderator)What:
“Recall Period – What Works and What Doesn’t?”When:
Wednesday, November 18, 9:00-9:45 a.m. Eastern time
As Conference Chair, Mr. Dixon will also deliver opening remarks
on the first day of the conference at 1:15 p.m. and on the second
day at 8:00 a.m.
In addition to its speaking engagements, Phase Forward will
participate in the following conferences throughout the month of
November:
What: 8th Annual Partnerships in
Clinical TrialsWhen: November 4-5, Rotterdam, The
NetherlandsWhere: Booth # 71
What: American Association of
Pharmaceutical Scientists Annual Meeting and Exposition
(AAPS)When: November 8-12, Los Angeles, Calif.Where:
Booth # 702
What: CDISC Interchange North
AmericaWhen: November 9-13, Baltimore, Md.Where:
Booth # 7
What: 2nd DIA Conference on Signal
Detection and Data MiningWhen: November 16-18, New York,
N.Y.
Members of the media interested in speaking with Phase Forward
should contact Maria Sumner at +44 1628 640743 or
maria.sumner@phaseforward.com or Meghan Locke at 781-672-3147 or
mlocke@chenpr.com.
About Phase Forward
Phase Forward is a leading provider of integrated data
management solutions for clinical trials and drug safety. Phase
Forward’s products and services have been utilized in over 10,000
clinical trials involving more than 1,000,000 clinical trial study
participants at over 300 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber
Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration,
GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono,
Novartis, Novo Nordisk, PAREXEL International, Procter &
Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about
Phase Forward is available at www.phaseforward.com.
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jul 2023 to Jul 2024
